Study Stopped
The study was terminated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
A Phase 3 Extension, Multicenter, Long Term Safety And Tolerability Trial Of Bapineuzumab (Aab 001, Eln115727) In Subjects With Alzheimer Disease Who Are Apolipoprotein E 4 Carriers And Participated In Study 3133k1-3001-us Or Study 3133k1-3001-ww.
3 other identifiers
interventional
494
19 countries
184
Brief Summary
The purpose of this study is to assess the long-term safety and tolerability of bapineuzumab in subjects with Alzheimer Disease who participated in study 3133K1-3001(NCT00676143). Over 250 sites will participate in over 26 countries. Subjects will receive bapineuzumab. Each subject's participation will last approximately 4 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 alzheimer-disease
Started Dec 2009
184 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2009
CompletedFirst Posted
Study publicly available on registry
October 20, 2009
CompletedStudy Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedResults Posted
Study results publicly available
January 1, 2016
CompletedJanuary 1, 2016
November 1, 2015
2.8 years
October 16, 2009
October 15, 2013
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Reporting a Serious Adverse Event
Safety was measured according to standard adverse event collection as described in the Adverse Event Section of the Results. Complete tables of events are provided there.
Up to Week 195
Secondary Outcomes (8)
Change From Base Study Baseline in Alzheimer's Disease Assesment Scale-Cognitive Subscale (ADAS-Cog/11) at Weeks 13, 26, 39, 52 and 78
Base Study Baseline, Weeks 13, 26, 39, 52 and 78
Change From Extension Study Baseline in ADAS-Cog/11 at Weeks 13, 26, 39, 52 and 78.
Base Study Baseline, Weeks 13, 26, 39, 52 and 78
Change From Base Study Baseline in Disability Assessment for Dementia (DAD) Score at Weeks 13, 26, 39, 52 and 78.
Base Study Baseline, Weeks 13, 26, 39, 52 and 78
Change From Extension Study Baseline in Disability Assessment for Dementia (DAD) Score at Weeks 13, 26, 39, 52 and 78.
Base Study Baseline, Weeks 13, 26, 39, 52 and 78
Change From Base Study Baseline in Neuropsychiatric Inventory (NPI) Score at Weeks 26, 52 and 78.
Base Study Baseline, Weeks 26, 52 and 78
- +3 more secondary outcomes
Study Arms (1)
Bapineuzumab 0.5 mg/kg
EXPERIMENTALInterventions
I.V., 0.5 mg/kg, infusion every 13 weeks for a total of 16 infusions.
Eligibility Criteria
You may qualify if:
- Subject has completed study 3133K1-3001 (Week 78) and brain magnetic resonance imaging (MRI) scan consistent with the diagnosis of Alzheimer Disease
- Mini-Mental Status Examination (MMSE) \>=10 at screening
- Caregiver able to attend all clinic visits with subject
You may not qualify if:
- Any medical or psychiatric contraindication or clinically significant abnormality that, in the investigator's judgment, will substantially increase the risk associated with the subject's participation in and completion of the study or could preclude the evaluation of the subject's response.
- Any significant brain MRI abnormality.
- Use of any investigational drugs or devices, other than bapineuzumab within the last 60 days prior to screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pfizerlead
Study Sites (184)
University Of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
UAB Center for Psychiatric Medicine
Birmingham, Alabama, 35294, United States
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
University of Alabama-Birmingham
Birmingham, Alabama, 35294, United States
Dedicated Clinical Research
Goodyear, Arizona, 85395, United States
Banner Alzheimer's Institute
Phoenix, Arizona, 85006, United States
Banner Good Samaritan Medical Center (Imaging
Phoenix, Arizona, 85006, United States
Jeffrey S. Gitt
Phoenix, Arizona, 85032, United States
Hope Research Institute
Phoenix, Arizona, 85050, United States
Clinical Trials, Inc.
Little Rock, Arkansas, 72205, United States
San Francisco Clinical Research Center
San Francisco, California, 94109, United States
Alpine Clinical Research Center, Inc.
Boulder, Colorado, 80304, United States
Associated Neurologist, PC
Boulder, Colorado, 80304, United States
Mile High Research Center
Denver, Colorado, 80218, United States
Associated Neurologists of Southern Connecticut, P.C.
Fairfield, Connecticut, 06824, United States
Bendheim Infusion Center, Greenwich Hospital
Greenwich, Connecticut, 06830, United States
Center for Healthy Aging, Greenwich Hospital
Greenwich, Connecticut, 06830, United States
Research Center for Clinical Studies, Inc.
Norwalk, Connecticut, 06851, United States
JEM Research LLC
Atlantis, Florida, 33462, United States
Medical Specialists of the Palm Beaches
Atlantis, Florida, 33462, United States
Brain Matters Research
Delray Beach, Florida, 33445, United States
Compass Research, LLC
Orlando, Florida, 32806, United States
Palm Beach Neurological Center, Advanced Research Consultants, Inc.
Palm Beach Gardens, Florida, 33418, United States
Neurostudies, Inc
Port Charlotte, Florida, 33952, United States
Southwest Florida Infusion Care, Inc.
Port Charlotte, Florida, 33952, United States
Roskamp Institute
Sarasota, Florida, 34234, United States
USF Health Byrd Alzheimer's Institute
Tampa, Florida, 33613, United States
Neuroscience Research Institute, LLC
Lawrenceville, Georgia, 30046, United States
Neurostudies.net
Lawrenceville, Georgia, 30046, United States
Alexian Brothers Neurosciences Institute Clinical Research
Elk Grove Village, Illinois, 60007, United States
Southern Illinois University School of Medicine Department
Springfield, Illinois, 62702, United States
Lake Charles Clinical Trials
Lake Charles, Louisiana, 70629, United States
Neuroscience Research of the Berkshires
Pittsfield, Massachusetts, 01201, United States
Springfield Neurology Associates, LLC
Springfield, Massachusetts, 01104, United States
Michigan State University
East Lansing, Michigan, 48824, United States
Michigan State University
East Lansing, Michigan, 48848, United States
Neurological Research Center of Hattiesburg Clinic
Hattiesburg, Mississippi, 39401, United States
The Center for Pharmaceutical Research, P.C.
Kansas City, Missouri, 64114, United States
Memory Enhancement Center of America, Inc.
Eatontown, New Jersey, 07724, United States
Alzheimer's Research Corp./Merician Institute for Aging
Paterson, New Jersey, 08759, United States
Toms River X-Ray, CT & MRI
Toms River, New Jersey, 08755, United States
MDR
Liverpool, New York, 13088, United States
Neurological Care of Central New York
Liverpool, New York, 13088, United States
Carolina Neuropsychological Services, Inc.
Raleigh, North Carolina, 27607, United States
Healthsouth Blue Ridge Surgery Center
Raleigh, North Carolina, 27607, United States
Raleigh Neurology Associates
Raleigh, North Carolina, 27607, United States
Wake Radiology Associates
Raleigh, North Carolina, 27607, United States
Ohio State Unviersity
Columbus, Ohio, 43210, United States
Summit Research Network(Oregon) Inc.
Portland, Oregon, 97210, United States
Providence Brain Institute-Cognitive Assessment Clinic
Portland, Oregon, 97225, United States
Providence Brain Institute
Portland, Oregon, 97225, United States
Abington Neurological Associates
Abington, Pennsylvania, 19001, United States
Abington Neurological Assoc
Abington, Pennsylvania, 19001, United States
Bington Memorial Hospital
Abington, Pennsylvania, 19001, United States
Clinical Trial Center, LLC
Jenkintown, Pennsylvania, 19046, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Rhode Island Mood and Memory Research Institute
East Providence, Rhode Island, 02914, United States
Medical University of South Carolina Hospitals and Clinics
Charleston, South Carolina, 29245, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Medical University of South Carolina
North Charleston, South Carolina, 29406, United States
Texas Neurology, P.A.
Dallas, Texas, 75214, United States
Innovative Clinical Trials
San Antonio, Texas, 78229, United States
Integra Clinical Research, LLC
San Antonio, Texas, 78231, United States
Vista Infusions
San Antonio, Texas, 78231, United States
Inventive Infusion Solutions
San Antonio, Texas, 78258, United States
Hospital Italiano de Buenos Aires
Buenos Aires, C1181ACH, Argentina
Gosford Hospital; Pharmacy Dept
Gosford, New South Wales, 2250, Australia
Hornsby Hospital
Hornsby, New South Wales, 2207, Australia
Royal Adelaide Memory Trials Centre
Adelaide, South Australia, 5000, Australia
Memory Unit 5C, Department of Neurology
Woodville South, South Australia, 5011, Australia
The Queen Elizabeth Hospital
Woodville South, South Australia, 5011, Australia
Heidelberg Repatriation Hospital
Heidelberg West, Victoria, 3081, Australia
Hollywood Hospital; Pharmacy Dept
Nedlands, Western Australia, 6009, Australia
The McCusker Foundation for Alzheimer's Disease Research
Nedlands, Western Australia, 6009, Australia
ZNA Middelheim
Antwerp, 2020, Belgium
AZ Sint-Jan Brugge-Oostende AV
Bruges, 8000, Belgium
Cliniques Universitaires St Luc
Brussels, 1200, Belgium
Universitair Ziekenhuis Gasthuisberg
Leuven, 3000, Belgium
H.-Hartziekenhuis Roeselare-Menen
Roeselare, 8800, Belgium
Psicomedica Research Group
Santiago, Chile, 7530193, Chile
Ita-Suomen Yliopisto
Kuopio, FIN-70210, Finland
University of Turku/CRST
Turku, FIN-20520, Finland
CHU de Dijon
Dijon, France, 21000, France
Hôpital Roger Salengro
Lille, France, 59037, France
Hôpital Pitié-Salpétrière
Paris, France, 75013, France
CHU Hôpital Pellegrin-Tripode
Bordeaux, 33076, France
Hopital Neurologique
Bron, 69677, France
CHU de Caen
Caen, 14033, France
Hôpitaux Civils de Colmar
Colmar, 68024, France
Hôpital la Timone
Marseille, 13385, France
Hôpital la Timone
Marseille, 13885, France
CHU Hôpital Gui de Chaulliac
Montpellier, 34295, France
CHU Nord - Hôpital Guillaume et René Laënnec
Nantes - Saint Herblain, 44093, France
Hôpital Cimiez
Nice, 06000, France
CHU La Milétrie
Poitiers, 86021, France
C.H.U de Reims
Reims, 51000, France
Department de Radiologie et d'Imagerie Medicale, Hopital Pontchaillou
Rennes, 35033, France
CHRU Hôtel Dieu
Rennes, 35064, France
Centre Hospitalier Universitaire Charles Nicolle
Rouen, 76031, France
Hôpital Purpan
Toulouse, 31059, France
CHU Purpan - Hôpital Casselardit
Toulouse, 31300, France
Sezione di Neurologia - Dipartimento di Neuroscienze
Ancona, 60020, Italy
Dipartimento di Neuroscienze,
Catania, 95123, Italy
Fondazione IRCCS- Istituto Neurologico Carlo Besta
Milan, 20133, Italy
Unita' Operativa C - Riabilitazione Neurologica
Roma, 00179, Italy
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
Yachiyo Hospital
Aichi, 446-8510, Japan
Kashiwado Hospital
Chiba, 260-8656, Japan
National Hospital Organization Chiba-East Hospital
Chiba, 260-8712, Japan
Nippon Medical School Chiba Hokusoh Hospital
Chiba, 270-1694, Japan
National Hospital Organization Kokura Medical Center
Fukuoka, 802-8533, Japan
Maebashi Red Cross Hospital
Gunma, 371-0014, Japan
Gunma University Hospital
Gunma, 371-8511, Japan
Shinozuka Hospital
Gunma, 375-0017, Japan
National Hospital Organization Hiroshima-nishi Medical Ctr.
Hiroshima, 739-0696, Japan
Kobe University Hospital
Hyōgo, 650-0017, Japan
Kagawa University Hospital
Kagawa, 761-0793, Japan
Nippon Medical School Musashi Kosugi Hospital
Kanagawa, 211-8533, Japan
Rakuwakai Otowa Hospital
Kyoto, 607-8062, Japan
National Hospital Organization Minami-Kyoto Hospital
Kyoto, 610-0113, Japan
National Hospital Organization Maizuru Medical Center
Kyoto, 625-8502, Japan
National Hospital Organization Matsumoto Medical Center
Nagano, 399-0021, Japan
National Hospital Organization Niigata National Hospital
Niigata, 945-8585, Japan
Okayama University Hospital
Okayama, 700-8558, Japan
National Hospital Organization Minami-Okayama Medical Center
Okayama, 701-0304, Japan
Osaka City University Hospital
Osaka, 545-8586, Japan
Kansai Medical University Takii Hospital
Osaka, 570-8507, Japan
Juntendo University Hospital
Tokyo, 113-8431, Japan
Juntendo Tokyo Koto Geriatric Medical Center
Tokyo, 136-0075, Japan
Tokyo Metropolitan Health and Med. Treatment Co. Ebara Hosp
Tokyo, 145-0065, Japan
Tokyo Medical University Hospital
Tokyo, 160-0023, Japan
Tokyo Medical University Hachioji Medical Center
Tokyo, 193-0944, Japan
National Hospital Organization Tokyo National Hospital
Tokyo, 204-8585, Japan
Geriatry
's-Hertogenbosch, 5223 GZ, Netherlands
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, 5223 GZ, Netherlands
Vrije Universiteit Medisch Centrum
Amsterdam, 1081 HV, Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, 8934 AD, Netherlands
The Memory Clinic Limited
Auckland, 0622, New Zealand
Christchurch Hospital
Christchurch, 8011, New Zealand
Signet Research
Christchurch, 8014, New Zealand
NZOZ Neuro-kard
Poznan, Poland, 61-289, Poland
Pallmed Spolka z o.o.
Bydgoszcz, 85-796, Poland
MCD Voxel
Poznan, 60-693, Poland
Pracownia Rezonansu Magnetycznego
Warsaw, 01-211, Poland
SP ZOZ Szpital Wolski
Warsaw, 01-211, Poland
Samodzielny Publiczny Centralny Szpital Kliniczny
Warsaw, 02-097, Poland
Hospitais Da Universidade De Coimbra
Coimbra, Coimbra District, 3000-075, Portugal
Hospital Fernando da Fonseca
Amadora, Lisbon District, 2720-276, Portugal
Hospital Santa Maria
Lisbon, Lisbon District, 1649-028, Portugal
Univerzitna nemocnica Bratislava
Bratislava, 825 56, Slovakia
Vseobecna nemocnica Rimavska Sobota
Rimavská Sobota, 979 12, Slovakia
Boithuso Caregivers
Johannesburg, Gauteng, 1709, South Africa
The Osteoporosis and Memory Centre
Johannesburg, Gauteng, 2196, South Africa
St Augustine's Medical Centre 2
Durban, KwaZulu-Natal, 4001, South Africa
Hospital General Universitario de Elche
Elche, Alicante, 03203, Spain
Hospital Universitario Son Espases
Palma de Mallorca, Balearic Islands, 07010, Spain
CLONUS
Palma de Mallorca, Balearic Islands, 07014, Spain
Hospital del Mar
Barcelona, Barcelona, 08003, Spain
Fundacio ACE Institut Catala de Neurociences Aplicades
Barcelona, Barcelona, 08014, Spain
Clinica CIMA
Barcelona, Barcelona, 08034, Spain
Hospital Mutua de Terrasa
Terrassa, Barcelona, 08221, Spain
Hospital Divino Valles
Burgos, Burgos, 09006, Spain
Hospital Virgen del Puerto
Plasencia, Caceres, 10600, Spain
Hospital de la Princesa
Madrid, Madrid, 28006, Spain
Hospital Clinico San Carlos
Madrid, Madrid, 28040, Spain
Hospital Universitario La Paz
Madrid, Madrid, 28046, Spain
Hospital de la Princesa
Madrid, 28006, Spain
Hospital Universitario Virgen de la Arrixaca
Murcia, 30120, Spain
Malmo University Hospital
Malmo, 21 224, Sweden
Minnes- och geriatrikmottagningen
Uppsala, 75185, Sweden
Memory Clinic Neuro-Psychologie Zentrum
Basel, Canton of Basel-City, CH-4031, Switzerland
Memory Service North, Grenoside Grange Hospital
Grenoside, Sheffield, S35 8QS, United Kingdom
Llandough Hospital, Universtity Hospital of Wales
Cardiff, Wales, CF4 4XW, United Kingdom
MAC UK Neuroscience Ltd.
Bradford, BDQ0DQ, United Kingdom
Clinical Investigation and Research Unit (CIRU)
Brighton, BN2 5BE, United Kingdom
Glasgow Memory Clinic
Glasgow, G20 OXA, United Kingdom
Dept. of Neurosciences Charing Cross Hospital
London, W6 8RF, United Kingdom
The Doctors Laboratory Ltd.
London, WIT 4EU, United Kingdom
Newcastle General Hospital
Newcastle upon Tyne, NE4 5PL, United Kingdom
Northampton General Hospital
Northampton, NN1 5BD, United Kingdom
Royal Hallamshire Hospital
Sheffield, S10 2JF, United Kingdom
Victoria Hospital
Swindon, SN3 6BW, United Kingdom
Alliance Medical
Wakefield, WF1 4TT, United Kingdom
Related Publications (1)
Ivanoiu A, Pariente J, Booth K, Lobello K, Luscan G, Hua L, Lucas P, Styren S, Yang L, Li D, Black RS, Brashear HR, McRae T. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies. Alzheimers Res Ther. 2016 Jun 23;8(1):24. doi: 10.1186/s13195-016-0193-y.
PMID: 27334799DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Pfizer ClinicalTrials.gov Call Center
- Organization
- Pfizer, Inc.
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2009
First Posted
October 20, 2009
Study Start
December 1, 2009
Primary Completion
October 1, 2012
Study Completion
November 1, 2012
Last Updated
January 1, 2016
Results First Posted
January 1, 2016
Record last verified: 2015-11